Nifty50 climbs Mount 13,000 on Covid-19 vaccine hope; Sensex rises 446 pts

The markets this month have surged more than 12 per cent on the back of more than $7 billion of foreign flows.
The benchmark Nifty50 index on Tuesday scaled the psychological 13,000-mark amid sustained buying by overseas investors. Favourable global cues after the beginning of US President-elect Joe Biden's formal transition also boosted sentiment. Besides, Biden’s planned nomination of former Fed chair Janet Yellen to be Treasury Secretary, considered to be of a dovish-bent, was welcomed by the markets.

The Nifty ended at 13,055 following a gain of 128 points, or 1 per cent. The Sensex, which kissed the 44,500-mark in intra-day deals, closed at 44,523, up 446 points, or 1.01  per cent.

Tuesday’s gains were underpinned by renewed buying in banking stocks. Signs of progress on a Covid-19 vaccine spurred hopes for a faster economic recovery. The Nifty had first topped the 12,000-mark during June last year. The index took 368 trading sessions to cover the 1,000-point milestone. In the interim, it had slipped below the 8,000-mark during the Covid-19-triggered sell-off in March. 

The markets this month have surged more than 12 per cent on the back of more than $7 billion of foreign flows.  The US election results and the progress in Covid-19 vaccine trails have buoyed sentiment.

“There were many concerns about the vaccine until last week. About the logistics of distributing the vaccines and their efficacy,” said Saurabh Mukherjea, founder, Marcellus Investments.

Another boost to the markets was US President Donald Trump's statement on Monday that his administration would co-operate with Biden's transition team. The US president's announcement came after a Michigan board-certified Biden as the winner. 

 
Banking and finance stocks, which have significant weighting in the benchmark indices, continued to rally on optimism that the Reserve Bank of India (RBI) would accept the recommendations of a working group.



Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel